MASSTERMIND Trademark

Scientific apparatus for analyzing proteins, blood, cell lysates and bodily fluids, namely, liquid chromatography apparatus and mass spectrometry apparatus for analyzing proteins, blood, cell lysates and bodily fluids; mass spectrometers for analyzing peptides and proteins; fluid separation apparatus for the separation of peptides and proteins for individual analysis; electronic databases recorded on computer media for use in medical diagnostics; computer software for use in the field of medical diagnostics; chromatography apparatus for laboratory use; liquid or gas chromatography apparatus for identifying peptides

Diagnostic preparations for medical use, namely, preparations for the diagnosis of disease, infection or illness, or predisposition to disease, infection or illness, or predisposition to disease, infection or illness; diagnostic preparations and substances for medical use in the medical analysis of proteins, blood and cell lysates and bodily fluids; protein and peptide biomarkers for use in the medical diagnosis of disease, infection or illness and predisposition to disease, infection or illness; diagnostic products and preparations and preparations for medical use comprising one or more biomarkers for the diagnosis of disease, infection or illness, and predisposition to disease, infection or illness; diagnostic products and preparations and preparations for medical use comprising one or more proteins or peptides or aptamers for the diagnosis of disease, infection or illness, and predisposition to disease, infection or illness; medical diagnostic kits comprised of one or more biomarkers and excipients for biomarker and protein analysis; medical diagnostic kits comprised of one or more peptides or aptamers and excipients for biomarker and protein analysis

Medical diagnosis services in the field of medical diagnosis of disease, illness and infection and in the field of identification of indicators of and for disease, illness and infection; medical services; medical diagnostic testing services; medical profiling of humans to predict their response to drugs; medical profiling for disease prognosis, diagnosis and progression, namely, preparing profiles of proteins present in patients for disease prognosis, diagnosis and progression; medical consultation services in the field of comparison and quantification of protein and peptide profiles; provision of medical information; medical analysis for the diagnosis and treatment of persons; provision of medical information arising from analysis for the diagnosis and treatment of persons; medical testing, namely, testing of proteins, blood, cell lysates and bodily fluids; leasing of medical equipment; provision of information from a computer database in the field of medical diagnostics and indicators of and for disease, illness and infection; testing services in the field of medical diagnosis of disease, illness and infection and in the field of identification of indicators of and for disease, illness and infection; analytical testing in the field of medical diagnosis of disease, illness and infection and in the field of identification of indicators of and for disease, illness and infection

Scientific and technological services and research and design in the field of medical diagnosis of disease, illness and infection and in the field of identification of indicators of and for disease, illness and infection; design and development of computer software and databases in the field of medical diagnosis; chemistry services; laboratory services in the field of medical diagnosis of disease, illness and infection and in the field of identification of indicators of and for disease, illness and infection; medical research services; medical and scientific research in the field of comparison and quantification of proteins and peptide profiles; scientific research services featuring discovery, identification, profiling, development and validation in the field of biomarkers, protein biomarkers and peptide biomarkers; scientific and technological services to identify, develop and validate biomarker assays; scientific and technological services to identify and develop peptides or aptamers as biomarkers for protease activity; scientific and technological services to identify and develop peptides including aptamers as biomarkers for inhibition of protease activity; laboratory analysis of proteins, blood and other biological matter